The pyruvate kinase activator etavopivat (FT-4202) limits pulmonary and systemic sequelae of sepsis in a mouse LPS model
AJP Lung Cellular and Molecular Physiology
Published online on May 20, 2026
Abstract
American Journal of Physiology-Lung Cellular and Molecular Physiology, Volume 330, Issue 6, Page L673-L684, June 2026.